pharmaphorum
JUNE 1, 2022
The technology behind virtual reality is rapidly advancing, allowing developers to create entire 3D hospitals for training purposes. In this article, Ben Hargreaves looks at how VR headsets are being used to better educate both healthcare professionals and the general public. Digital healthcare solutions are being talked about with increasing frequency.
Outsourcing Pharma
JUNE 1, 2022
Lithuaniaâs life sciences industry is growing at one of the fastest rates in Europe. Ahead of BIO, Innovation Agency Lithuania explains what the countryâs plans are for future growth in the area and how this is built upon students heading into STEM studies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
NY Times
JUNE 3, 2022
As the number of cases outside Africa approaches 800, governments are scrambling for a limited pool of vaccines and treatments with unclear effectiveness.
Pharma Times
MAY 31, 2022
‘Act4Biosimilars’ will improve patient access and increase adoption in over 30 countries by 2030
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
MAY 30, 2022
The American Society of Clinical Oncology, or ASCO, conference is just around the corner, but one subgroup of cancer researchers just had their own gathering, as breast cancer researchers came together in person for the first time since the start of the pandemic at the ESMO Breast Cancer congress. pharmaphorum sat down with Sunil Verma, global head of oncology, medical, at AstraZeneca, to discuss three studies that were presented at the show, which demonstrate a few of the ways oncology is advan
Drug Channels
JUNE 2, 2022
Today’s guest post comes from Bonnie Briggs, Associate Director of Clinical Effectiveness at Wolters Kluwer, Health. Bonnie describes how pharmaceutical care would benefit from standard medical record identification. She then discusses the practical issues behind implementing and adopting such a system. To learn more, download the Wolters Kluwer free ebook: Drug Data Unity: Realistic and Idealistic Futures for Information Exchange.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Pharma Times
MAY 30, 2022
The injection is given in combination with chemotherapy and administered once every three weeks
pharmaphorum
MAY 31, 2022
Sanofi and Regeneron should hear from the FDA in the autumn whether it will approve their blockbuster immunology drug Dupixent as a therapy for rare skin disease prurigo nodularis (PN). The US regulator has granted Dupixent (dupilumab) a six-month priority review in PN and is due to deliver a verdict by 30 September, offering patients hope of a first-approved therapy for the highly-debilitating disease.
Drug Channels
MAY 30, 2022
Summer unofficially began over the weekend. Let’s turn up the heat with these sizzling news bites straight from the Drug Channels grill: SaveonSP gets sued Thoughts on the Medicaid accumulator rule opinion CVS buys AmerisourceBergen’s specialty pharmacy Fresh data on hospitals’ cancer drug profiteering Plus, Dr. Glaucomflecken explains Aetna’s prior authorization policies.
NY Times
MAY 31, 2022
Many insurance companies refuse to cover new weight loss drugs that their doctors deem medically necessary.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Times
JUNE 1, 2022
The drug is used to treat seizures caused by this rare syndrome that is a form of epilepsy
pharmaphorum
MAY 30, 2022
In future, blood samples may be taken by an autonomous robot rather than a healthcare professional – if Dutch developer Vitestro can get its prototype approved for marketing. Vitestro’s blood drawing (phlebotomy) robot is designed to offer a solution to what the company says is a growing shortage of healthcare personnel, coupled with rising demand for blood tests with billions carried out every year worldwide.
Drug Patent Watch
MAY 30, 2022
Annual Drug Patent Expirations for VIMOVO Vimovo is a drug marketed by Horizon and is included in one NDA. It is available from one supplier. There are nine patents protecting…. The post New patent expiration for Horizon drug VIMOVO appeared first on DrugPatentWatch - Make Better Decisions.
Outsourcing Pharma
JUNE 1, 2022
The Lifebit CloudOS will be employed to create a Federate Trusted Research Environment within the centerâs supercomputing cluster to handle data management.
Pharma Times
JUNE 1, 2022
Apixaban will be available for the prevention of stroke and deep vein thrombosis
pharmaphorum
JUNE 1, 2022
GlaxoSmithKline is due to complete the split from its consumer health decision – now renamed Haleon – next month, with a listing for the new company on the London Stock Exchange set for 18 July. GSK said it has now filed a prospectus for the submission of Haleon’s ordinary shares to the stock market with the Financial Conduct Authority (FCA), and is awaiting approval for the move.
Drug Patent Watch
JUNE 3, 2022
Annual Drug Patent Expirations for JATENZO Jatenzo is a drug marketed by Clarus and is included in one NDA. It is available from one supplier. There are seven patents protecting…. The post New patent for Clarus drug JATENZO appeared first on DrugPatentWatch - Make Better Decisions.
Outsourcing Pharma
JUNE 1, 2022
A Touch, the Black Breast Cancer Alliance leader discusses how a grant from Genentech is helping the organization break down barriers in care and research.
Pharma Times
MAY 31, 2022
Antibody addresses high unmet medical need in rapidly growing kidney transplant market
pharmaphorum
MAY 30, 2022
The World Health organisation’s latest assessment of the monkeypox outbreak is that it poses a moderate threat to public health, as cases of the infection continue to rise. In an update posted yesterday, the WHO said it had received reports of 257 confirmed cases of monkeypox from 23 countries, 106 of them from the UK and 49 from Portugal, with another 120 suspected cases being investigated.
Definitive Healthcare
JUNE 3, 2022
Healthcare data and analytics buying guide for software & IT companies mgathers Fri, 06/03/2022 - 09:35 Teaser Image Data & analytics buying guide for software & IT companies.png Teaser Content In this buyer’s guide, we’ll share a step-by-step best-practice approach to selecting the right data and analytics source for your organization. Resource Type Buyer's Guides Marketo form number 1748 Case Study Case Study Case Study Hicuity Health grows qualified lead volume and streamlines commercial team
The Happy PharmD
JUNE 3, 2022
Evaluations— they were a necessary evil of my job. I didn’t like writing them, I didn’t like giving them. My staff didn’t like getting them. So why did I do them? Two reasons: 1) Management thought that employees liked or needed feedback about how well they were performing their job, and 2) evaluations were usually tied to some kind of merit increase.
Pharma Times
MAY 30, 2022
NRG Therapeutics announces multi-million Innovate UK Award to develop treatments for Parkinson’s and motor neurone disease
pharmaphorum
MAY 30, 2022
GlaxoSmithKline is reportedly close to finding a development partner for a major new investment project in the UK that will see a new bioscience cluster built near its research centre in Stevenage. The pharma group said last year it was looking for a collaborator to develop a 33-acre block of land in the Hertfordshire town into a hub for life science companies, creating up to 5,000 jobs over the next decade.
EMCrit Project
JUNE 2, 2022
Neuro-oncologic emergencies are commonly encountered in critical care. Rapidly evolving biological therapies for cancer offer patients exciting benefits, but have also created new sets of complications (e.g., checkpoint inhibitor-induced encephalitis). Patients may be suffering from complications of the malignancy itself, complications of therapy, or wholly unrelated problems.
Pharma Mirror
JUNE 2, 2022
SINGAPORE, Azelis, a leading innovation service provider in the specialty chemicals and food ingredients industry, announces the opening of its Regional Innovation Center (RIC) for Food & Nutrition (F&N) in Singapore, further demonstrating the Group’s commitment to continuously invest in its innovation capabilities. The RIC will generate a wealth of possibilities for food innovation towards healthier and tastier solutions through pioneering, ready-to-use formulations with advance
EnlivenHealth
JUNE 1, 2022
The old adage goes, “You have to spend money to make money.” When it comes to operating your own business, that’s absolutely true. And one of the best ways for your pharmacy to make more money — and to better help your patients — is to provide clinical care services for your community. But the The post How Pharmacy Intelligence Can Fund Your Clinical Care Practice appeared first on Pharmacy Software Solutions | FDS.
pharmaphorum
JUNE 1, 2022
Astellas has become the latest big pharma company to sink some money into immuno-oncology start-up GO Therapeutics, forging an alliance to develop antibodies targeting two glycoprotein targets. The Japanese drugmaker is paying $20.5 million upfront to get the ball rolling, while milestone and other payments could take the total value of the deal up to $783.5 million.
EMCrit Project
JUNE 1, 2022
One and a half years ago, a landmark study by Sjoding et al. found that critically ill Black patients were more likely than White patients to have falsely reassuring pulse oximetry measurements (discussed here).?1? Subsequently, six sizable studies have been published on this topic. Since this is of critical importance to acute care medicine, it's […].
Drug Patent Watch
MAY 31, 2022
Annual Drug Patent Expirations for OLUMIANT Olumiant is a drug marketed by Eli Lilly And Co and is included in one NDA. It is available from one supplier. There are…. The post New patent for Eli Lilly drug OLUMIANT appeared first on DrugPatentWatch - Make Better Decisions.
Fusion Pharmacy
MAY 31, 2022
Everyone experiences stress at some point in their lives. For some people, stress is a normal part of their everyday lives, and they gradually learn to cope with it in healthy ways. For others, stress can be more debilitating and may even lead to health problems. If you find yourself struggling to cope with stress, supplements can help. Let’s talk about which supplements can help you relieve your stress and where you can find the best supplements.
pharmaphorum
JUNE 1, 2022
Medical imaging specialist Median Technologies has launched a new business unit that will provide decision-making tools – underpinned by artificial intelligence – for sponsors of clinical trials in oncology. The new Imaging Lab business will deploy AI, data mining, and radiomics technologies to medical imaging data generated in cancer trials, said Median.
EMCrit Project
MAY 30, 2022
Movement disorders are encountered more frequently in the critical care unit than one might realize. For example Parkinson's disease alone affects ~1% of patients over sixty years old (often requiring careful consideration in medication management, to avoid either psychosis or Parkinsonism-hyperpyrexia syndrome). Other disorders are less common, but their recognition may be critical (e.g., propofol […].
Drug Patent Watch
MAY 31, 2022
Annual Drug Patent Expirations for EPHEDRINE+SULFATE Ephedrine Sulfate is a drug marketed by Akorn, Amneal, Dr Reddys Labs Ltd, Endo Ventures, Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma,…. The post New patent for Endo Ventures drug EPHEDRINE SULFATE appeared first on DrugPatentWatch - Make Better Decisions.
Fusion Pharmacy
MAY 30, 2022
In recent years, online mental health coaching has gained considerable popularity. More people benefit from seeking help from a professional, as they don’t always have the time or money to go to traditional therapy sessions. Let’s talk more about what online mental health coaching is, its benefits, and where you can find the best mental health coaching.
Expert insights. Personalized for you.
142 
Let's personalize your content